Clinical trial

Progression of Striatal and Extrastriatal Degeneration in PD and PSP Patients

NCT03840252

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DIAGNOSTIC_TEST · Unmapped registry intervention 3D gait analysis Find medicine records · Find other trials using this name

DIAGNOSTIC_TEST · Unmapped registry intervention rsfMRI Find medicine records · Find other trials using this name

DIAGNOSTIC_TEST · Unmapped registry intervention Montreal Cognitive assesment (MoCA) Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Progression of Striatal and Extrastriatal Degeneration in PD and PSP Patients

Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2015-09-23

PhaseNA

Conditions

Parkinson Disease (PD)unresolved

Paralysis; Supranuclearunresolved

Interventions

3D gait analysisDIAGNOSTIC_TEST

rsfMRIDIAGNOSTIC_TEST

Montreal Cognitive assesment (MoCA)DIAGNOSTIC_TEST

Sponsors & collaborators

IRCCS San Raffaele Romalead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03840252 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.